Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moti L Kashyap

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Current Cardiology Reports|October 16, 2003
Niacin, lipids, and heart diseaseShaista Malik, Moti L Kashyap
Expert Review of Cardiovascular Therapy|March 20, 2004
Dyslipidemia treatment: current considerations and unmet needsShaista Malik, Moti L Kashyap
Current Opinion in Cardiology|June 16, 2005
Pharmacologic augmentation of high-density lipoproteins: mechanisms of currently available and emerging therapiesC Daniel Meyers, Moti L Kashyap
Endocrinology and Metabolism Clinics of North America|July 21, 2004
Management of the metabolic syndrome-nicotinic acidC Daniel Meyers, Moti L Kashyap
Expert Review of Cardiovascular Therapy|November 21, 2008
Fixed-dose combination of extended-release niacin plus simvastatin for lipid disordersAnthony N Vo, Moti L Kashyap
The American Journal of Cardiology|June 14, 2008
Mechanism of action of niacinVaijinath S Kamanna, Moti L Kashyap
Current Opinion in Cardiology|June 26, 2004
Pharmacologic elevation of high-density lipoproteins: recent insights on mechanism of action and atherosclerosis protectionC Daniel Meyers, Moti L Kashyap
The American Journal of Cardiology|December 6, 2007
Nicotinic acid (niacin) receptor agonists: will they be useful therapeutic agents?Vaijinath S Kamanna, Moti L Kashyap
Expert Opinion on Pharmacotherapy|December 11, 2002
Niacin extended-release/lovastatin: combination therapy for lipid disordersYong S K Moon, Moti L Kashyap
Pharmacotherapy|December 9, 2004
Pharmacologic treatment of type 2 diabetic dyslipidemiaYong S K Moon, Moti L Kashyap
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Current Cardiology Reports|October 16, 2003
Niacin, lipids, and heart diseaseShaista Malik, Moti L Kashyap
Expert Review of Cardiovascular Therapy|March 20, 2004
Dyslipidemia treatment: current considerations and unmet needsShaista Malik, Moti L Kashyap
Current Opinion in Cardiology|June 16, 2005
Pharmacologic augmentation of high-density lipoproteins: mechanisms of currently available and emerging therapiesC Daniel Meyers, Moti L Kashyap
Endocrinology and Metabolism Clinics of North America|July 21, 2004
Management of the metabolic syndrome-nicotinic acidC Daniel Meyers, Moti L Kashyap
Expert Review of Cardiovascular Therapy|November 21, 2008
Fixed-dose combination of extended-release niacin plus simvastatin for lipid disordersAnthony N Vo, Moti L Kashyap
The American Journal of Cardiology|June 14, 2008
Mechanism of action of niacinVaijinath S Kamanna, Moti L Kashyap
Current Opinion in Cardiology|June 26, 2004
Pharmacologic elevation of high-density lipoproteins: recent insights on mechanism of action and atherosclerosis protectionC Daniel Meyers, Moti L Kashyap
The American Journal of Cardiology|December 6, 2007
Nicotinic acid (niacin) receptor agonists: will they be useful therapeutic agents?Vaijinath S Kamanna, Moti L Kashyap
Expert Opinion on Pharmacotherapy|December 11, 2002
Niacin extended-release/lovastatin: combination therapy for lipid disordersYong S K Moon, Moti L Kashyap
Pharmacotherapy|December 9, 2004
Pharmacologic treatment of type 2 diabetic dyslipidemiaYong S K Moon, Moti L Kashyap
Pageof 6